Antero Midstream posts strong Q4 results, 8% EBITDA growth, debt reduction, and a 5%+ dividend yield. See why we are on the ...

argenx has a lower P/E than the aggregate P/E of 77.7 of the Biotechnology industry. Ideally, one might believe that the ...

Unity's AI-driven Vector model and Create business drive growth, with a focus on non-gaming sectors. See why we are bullish ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Track Fermenbio share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss ...

Analysts may not have crystal balls, but they’re pretty bullish on Vertex’s 2028 outlook, despite its rocky stock performance ...

Softening forecasts for bank earnings are a symptom of the wider economic and policy uncertainty facing the U.S.

Over the last 7 days, the United States market has risen by 2.1%, contributing to a year-long climb of 8.1%, with earnings forecasted to grow by 14% annually. In this dynamic environment, discovering ...

Aptevo Therapeutics reports strong remission rates in AML patients using mipletamig plus ven/aza, with Cohort 2 enrollment ...

The United States market has shown resilience, climbing 2.1% over the last week and rising 8.1% over the past year, with earnings projected to grow by 14% annually in the coming years. In this ...

Merck KGaA operates in three key segments: healthcare, life science, and electronics. Over the past decade, strategic acquisitions and divestments have strengthened its position in these industries, ...